Literature DB >> 2571821

Hypophosphataemic rickets: final height and clinical symptoms in adults.

G B Stickler1, B Z Morgenstern.   

Abstract

The heights and symptoms of 52 patients, aged at least 18 years, with X-linked hypophosphataemic rickets were analysed retrospectively; 47 had been seen as children and 5 were adult at their first examination. 2 patients were lost to follow-up. 3 patients had died but their adult heights were known. There was no evidence that any form of treatment (ie, vitamin D in high doses, vitamin D plus phosphate supplements, or calcitriol plus phosphate) had any effect on adult height, symptoms, or alkaline phosphatase levels. There was a negative relation between adult height and the number of osteotomies undergone. The complications of treatment, such as renal failure, which occurred secondary to vitamin D intoxication in 3 patients in their twenties, may outweight any possible benefits. Until a treatment is established as effective in controlled trials, it may be better that these patients remain untreated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2571821     DOI: 10.1016/s0140-6736(89)91559-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  12 in total

1.  X linked hypophosphataemia: treatment, height gain, and nephrocalcinosis.

Authors:  G S Reusz; P F Hoyer; M Lucas; H P Krohn; J H Ehrich; J Brodehl
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

2.  Growth in PHEX-associated X-linked hypophosphatemic rickets: the importance of early treatment.

Authors:  Catherine Quinlan; Katie Guegan; Amaka Offiah; Richard O' Neill; Melanie P Hiorns; Sian Ellard; Detlef Bockenhauer; William Van't Hoff; Aoife M Waters
Journal:  Pediatr Nephrol       Date:  2011-11-20       Impact factor: 3.714

3.  CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders.

Authors:  Xiuying Bai; Dengshun Miao; Sophia Xiao; Dinghong Qiu; René St-Arnaud; Martin Petkovich; Ajay Gupta; David Goltzman; Andrew C Karaplis
Journal:  J Clin Invest       Date:  2016-01-19       Impact factor: 14.808

4.  Association between X-linked hypophosphatemic rickets and Klinefelter's syndrome: effects on growth and body proportion.

Authors:  G I Baroncelli; S Bertelloni; G Perri; G Saggese
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

5.  Medullary nephrocalcinosis in nephropathic cystinosis.

Authors:  D S Theodoropoulos; T H Shawker; C Heinrichs; W A Gahl
Journal:  Pediatr Nephrol       Date:  1995-08       Impact factor: 3.714

Review 6.  Adverse renal and metabolic effects associated with oral sodium phosphate bowel preparation.

Authors:  Eliot C Heher; Samuel O Thier; Helmut Rennke; Benjamin D Humphreys
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-02       Impact factor: 8.237

7.  Growth hormone secretion in poorly growing children with renal hypophosphataemic rickets.

Authors:  G Saggese; G I Baroncelli; S Bertelloni; G Perri
Journal:  Eur J Pediatr       Date:  1994-08       Impact factor: 3.183

Review 8.  Therapeutics of X-linked hypophosphatemic rickets.

Authors:  K Latta; S Hisano; J C Chan
Journal:  Pediatr Nephrol       Date:  1993-12       Impact factor: 3.714

9.  Patients with Hypophosphatemic Osteomalacia Need Continuous Treatment during Adulthood.

Authors:  Eri Suzuki; Makoto Yamada; Daisuke Ariyasu; Masako Izawa; Junko Miyamoto; Shinobu Koto; Yukihiro Hasegawa
Journal:  Clin Pediatr Endocrinol       Date:  2009-02-19

10.  Two novel variants of the PHEX gene in patients with X‑linked dominant hypophosphatemic rickets and prenatal diagnosis for fetuses in these families.

Authors:  Hong Liao; Hong-Mei Zhu; Hong-Qian Liu; Ling-Ping Li; Shan-Ling Liu; He Wang
Journal:  Int J Mol Med       Date:  2018-01-18       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.